Top Menu

Archive | DTC-In-Perspective by Bob Ehrlich

Bob Ehrlich

DTC in Perspective: FDA Research Reinforces Warning Rationale

Many recent FDA warning letters involve what they say are distracting visuals during risk discussion. Last year Otezla and Toujeo were cited for that. A recent study using eye tracking reinforced their view that visual backgrounds on TV ads are potentially hurting comprehension of risks. Drug makers frequently mention some of the risks using supers […]

Continue Reading 0